Melanoma/Skin Cancer News

Flawed convolutional neural networks used to assess melanoma lesions have led to misclassification and misdiagnosis of those lesions, according to a letter to the editor in Journal of Investigative Dermatology.

Nicotinamide, a form of vitamin B3, could protect skin cells from damaging, cancer-causing ultraviolet B exposure, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.

John A. Glaspy, MD, MPH, has been named the inaugural Simms/Mann Family Foundation endowed chair in integrative oncology at University of California, Los Angeles.

Each month, John Sweetenham, MD, and I review a stack of reports from conferences and the international literature for reporting in HemOnc Today.

Angiogenesis appeared to be driven by an increase in the protein sFRP2 in the aged tumor microenvironment as VEGF decreased among older patients with melanoma, according to results of a study published in Clinical Cancer Research.

The FDA approved the FoundationOne CDx test to help identify certain neurotrophic receptor tyrosine kinase gene fusions in patients with solid tumors eligible for treatment with larotrectinib, according to a press release from the agency.

Fewer basal cell carcinomas were treated after the declaration of the COVID-19 pandemic, with those being treated having a higher histopathological upgrade rate, according to a study.

Neoadjuvant photodynamic therapy before surgery for squamous cell carcinoma in situ may facilitate simpler surgical interventions, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Most dermatologic surgeons recommended pharmacologic interventions to prevent nonmelanoma skin cancer, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Renowned cancer researcher Steven A. Rosenberg, MD, PhD, has been awarded the 2020 Samuel D. Gross Prize for surgical research.